Susquehanna International Group’s Intercure INCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-16,600
Closed -$33.4K 12672
2024
Q3
$33.4K Sell
16,600
-30,900
-65% -$64.8K ﹤0.01% 11509
2024
Q2
$95.5K Buy
47,500
+31,400
+195% +$85.3K ﹤0.01% 11058
2024
Q1
$43.6K Buy
+16,100
New +$27.4K ﹤0.01% 11607
2023
Q4
Sell
-15,300
Closed -$24.2K 12802
2023
Q3
$24.2K Buy
+15,300
New +$24.4K ﹤0.01% 11555

Other funds holding INCR

Susquehanna International Group's INCR Position: Q4 2023 in Review

Susquehanna International Group sold out of Intercure (INCR) in Q4 2023, closing a stake of 14,658 shares — an estimated $23.2K sold.

Susquehanna International Group first reported a position in INCR in Q2 2023 and held it in 2 quarters. The position peaked at $23.2K in Q3 2023. 18 funds tracked by Wall St. Rank hold INCR as of Q4 2023.

  • Susquehanna International Group reported no remaining Intercure position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 14,658 Intercure shares in Q4 2023, an estimated $23.2K.
  • Susquehanna International Group first reported a position in Intercure in Q2 2023 and held it in 2 quarters.
  • Susquehanna International Group's Intercure position peaked at $23.2K in Q3 2023.
  • 18 funds tracked by Wall St. Rank held Intercure as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.